C Juelch
YOU?
Author Swipe
View article: Platelet Reactivity and Fibrin Clot-Strength as assessed by TEG in Patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention
Platelet Reactivity and Fibrin Clot-Strength as assessed by TEG in Patients with Atrial Fibrillation undergoing Percutaneous Coronary Intervention Open
Platelet reactivity (PR) in clopidogrel-treated patients undergoing percutaneous coronary syndrome (PCI) associates with ischemic and bleeding risk. The aim was to investigate the association of PR and global hemostasis with this risk in p…
View article: Increased clot strength following transcatheter aortic valve replacement
Increased clot strength following transcatheter aortic valve replacement Open
Background Patients treated with transcatheter aortic valve replacement (TAVR) are at high risk for bleeding and ischemic events. Thrombelastography (TEG) parameters are associated with thromboembolic and bleeding risk. TEG may be used to …
View article: High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation
High rates of high on-aspirin platelet reactivity in patients after transcatheter aortic valve implantation Open
Background Guidelines recommend aspirin monotherapy in patients after transcatheter aortic valve replacement (TAVR) without an indication for oral anticoagulation. The prevalence of high on-aspirin platelet reactivity (HAPR) varies from 1%…
View article: Poster No. 018 Association of Cytochrome P450 2C19 polymorphisms with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention
Poster No. 018 Association of Cytochrome P450 2C19 polymorphisms with ischemic and bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention Open
Introduction Patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI) receive clopidogrel and direct oral anticoagulation. Platelet inhibition by clopidogrel varies according to CYP2C19 genotype. This study aim…